APA (7th ed.) Citation

HH, Y., NR, F., JP, M., PD, S., DW, V., R, P., . . . MP, G. (2016). Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance). Annals of oncology : official journal of the European Society for Medical Oncology, 27(2), 339. https://doi.org/10.1093/annonc/mdv543

Chicago Style (17th ed.) Citation

HH, Yoon, et al. "Gene Expression Profiling Identifies Responsive Patients with Cancer of Unknown Primary Treated with Carboplatin, Paclitaxel, and Everolimus: NCCTG N0871 (alliance)." Annals of Oncology : Official Journal of the European Society for Medical Oncology 27, no. 2 (2016): 339. https://doi.org/10.1093/annonc/mdv543.

MLA (9th ed.) Citation

HH, Yoon, et al. "Gene Expression Profiling Identifies Responsive Patients with Cancer of Unknown Primary Treated with Carboplatin, Paclitaxel, and Everolimus: NCCTG N0871 (alliance)." Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 27, no. 2, 2016, p. 339, https://doi.org/10.1093/annonc/mdv543.